Antiadhesive sites present in the fibronectin type III-like repeats of human plasma fibronectin.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Biological and Pharmaceutical Bulletin

• Publication date

  2007-05-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1248/BPB.30.891PMID 17473431
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A fibronectin fragment induces tumor necrosis factor production of rat basophilic leukemia cells.

  2004cited by this paper
• Fibronectin peptides derived from two distinct regions stimulate adipocyte differentiation by preventing fibronectin matrix assembly.

  2002cited by this paper
• A new type of antimetastatic peptide derived from fibronectin.

  2002cited by this paper
• Integrins: bidirectional, allosteric signaling machines.

  2002cited by this paper
• Anoikis mechanisms.

  2001cited by this paper
• Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival.

  2001cited by this paper
• SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury.

  2001cited by this paper
• The de-adhesive activity of matricellular proteins: is intermediate cell adhesion an adaptive state?

  2001cited by this paper
• Thrombospondins as matricellular modulators of cell function.

  2001cited by this paper
• The fibronectin-derived antiadhesive peptides suppress the myofibroblastic conversion of rat hepatic stellate cells.

  2001cited by this paper
• Regulation of tissue injury responses by the exposure of matricryptic sites within extracellular matrix molecules.

  2000cited by this paper
• The fibronectin-derived anti-adhesive peptide III14-2 suppresses adhesion and apoptosis of leukemic cell lines through down-regulation of protein-tyrosine phosphorylation.

  2000cited by this paper
• Interaction with heparin and matrix metalloproteinase 2 cleavage expose a cryptic anti-adhesive site of fibronectin.

  2000cited by this paper
• Modulation of apoptotic cell death by extracellular matrix proteins and a fibronectin-derived antiadhesive peptide.

  1998cited by this paper
• The P2Y1 receptor is necessary for adenosine 5'-diphosphate-induced platelet aggregation.

  1998cited by this paper
• Extracellular Matrix Survival Signals Transduced by Focal Adhesion Kinase Suppress p53-mediated Apoptosis

  1998cited by this paper
• Integrin affinity modulation.

  1998cited by this paper
• Identification of the anti-adhesive site buried within the heparin-binding domain of fibronectin.

  1997cited by this paper
• Structural interlock between ligand-binding site and stalk-like region of beta1 integrin revealed by a monoclonal antibody recognizing conformation-dependent epitope.

  1997cited by this paper
• Pieces of eight: bioactive fragments of extracellular proteins as regulators of angiogenesis.

  1997cited by this paper
• Fibronectin harbors anticell adhesive activity.

  1996cited by this paper
• Integrin activation by R-ras.

  1996cited by this paper
• Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix.

  1996cited by this paper
• Inhibition of cell adhesion by anti-adhesive molecules.

  1995cited by this paper
• Integrins: emerging paradigms of signal transduction.

  1995cited by this paper
• Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions.

  1993cited by this paper
• Integrins: versatility, modulation, and signaling in cell adhesion.

  1992cited by this paper
• Signal transduction by integrin receptors for extracellular matrix: cooperative processing of extracellular information.

  1992cited by this paper
• VCAM-1 on activated endothelium interacts with the leukocyte integrin VLA-4 at a site distinct from the VLA-4/fibronectin binding site.

  1990cited by this paper
• Tenascin interferes with fibronectin action.

  1988cited by this paper

• Bioactive TNIIIA2 Sequence in Tenascin-C Is Responsible for Macrophage Foam Cell Transformation; Potential of FNIII14 Peptide Derived from Fibronectin in Suppression of Atherosclerotic Plaque Formation

  2024cites this paper
• The type-VI secretion system of the beneficial symbiont Vibrio fischeri

  2023cites this paper
• Exposure of the cryptic de-adhesive site FNIII14 in fibronectin molecule and its binding to membrane-type eEF1A induce migration and invasion of cancer cells via β1-integrin inactivation.

  2020cites this paper
• Regulation of the Innate Immune Response by Fibronectin: Synergism between the III-1 and EDA Domains

  2014cites this paper
• A Novel Mechanism Underlying the Basic Defensive Response of Macrophages against Mycobacterium Infection

  2014cites this paper
• Eukaryotic Translation Elongation Factor 1A Induces Anoikis by Triggering Cell Detachment*

  2012cites this paper
• The cell adhesion and proliferation activities of a peptide derived from human tenascin-C are dependent on two Ile residues.

  2012cites this paper
• Cell Regulation through Membrane Rafts/Caveolae

  2012cites this paper
• Biomechanical ECM Switches and Tumor Metastasis

  2011cites this paper
• The First Type III Repeat in Fibronectin Activates an Inflammatory Pathway in Dermal Fibroblasts*

  2010cites this paper
• ASARM‐truncated MEPE and AC‐100 enhance osteogenesis by promoting osteoprogenitor adhesion

  2008cites this paper
• Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.

  2008cites this paper
• Impact of the non‐cellular tumor microenvironment on metastasis: Potential therapeutic and imaging opportunities

  2007influential citation